Anascorp Market Report 2026

Anascorp Market Overview

• The Anascorp market growth in the historic period has been driven by incidence of scorpion envenomation, emergency department utilization • Market expansion is supported by climate driven venom spread, improved emergency access • Growth Driver: Growing Snakebite Incidents Drive Expansion Of The Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Anascorp Market?

Anascorp is a biopharmaceutical product used as a therapeutic antivenom for treating scorpion venom toxicity, especially from dangerous species of Centruroides. Its production involves biological manufacturing processes, and it provides essential treatment to those who experience severe reactions to scorpion stings. The main types of products in anascorp are human antivenoms, veterinary antivenoms, and combination antivenoms. Human antivenoms are medicines designed to treat venomous bites or stings in humans. The various clinical indications include scorpion stings, and snake bites. It was distributed through various sales channels, including direct sales, wholesalers, and online pharmacies, for various end users such as adults, geriatrics, and pediatrics.

What Is The Anascorp Market Growth Forecast?

The growth in the forecast period can be attributed to climate driven venom spread, improved emergency access, expansion of trauma centers, public health funding, increased awareness of venom treatment protocols. Major trends in the forecast period include continued demand for antivenom therapies, hospital based emergency toxicology care, focus on region specific envenomation, improved cold chain biologic handling, public health preparedness for venom incidents.

What Are The Drivers Of The Anascorp Market?

An increase in snakebite incidents is expected to propel the growth of the anascorp market going forward. Snakebite incidents refer to situations where a person is bitten by a snake, potentially leading to health risks that require urgent medical treatment. The increase in snakebite incidents is primarily due to urbanization, climate change, human encroachment on snake habitats, limited access to medical care, and a lack of awareness and preventative measures. Anascorp, an innovative antivenom treats snakebite incidents by neutralizing venom from certain species of venomous snakes, thereby reducing the risk of severe symptoms, organ damage, or death, and is particularly beneficial in regions where snakebites are prevalent, providing timely and effective treatment for patients. For instance, in September 2023, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, around 5.4 million snakebites occur annually, causing 81,410 to 137,880 deaths and numerous permanent disabilities. Therefore, the increase in snakebite incidents leads to growth of the anascorp industry. The rising incidence of infectious diseases is expected to propel the growth of the anascorp market going forward. Infectious diseases refer to illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites. The rising incidence of infectious diseases is largely driven by increased global travel, which facilitates the spread of pathogens, and declining vaccination rates, which lead to the resurgence of preventable diseases such as measles. Anascorp is used to treat envenomation from venomous snakebites by neutralizing the venom, preventing severe systemic effects and potential infections caused by tissue damage. For instance, in February 2024, according to the UK Health Security Agency, a UK-based government agency, tuberculosis (a contagious bacterial infection that primarily affects the lungs) cases in England rose to 4,850 in 2023, an increase of 10.7% from 4,380 cases in 2022. Therefore, the rising incidence of infectious diseases is driving the growth of the anascorp industry. The rising healthcare expenditure is expected to propel the growth of the anascorp market going forward. Healthcare expenditure refers to the total amount of financial resources spent on healthcare services, including medical treatments, hospital care, medications, and public health initiatives, by governments, businesses, and individuals. The increasing demand for healthcare expenditure is due to the rising prevalence of chronic diseases, which require long-term and costly treatments. Rising healthcare expenditure enhances anascorp utilization by improving access to critical antivenom treatments, enabling hospitals to better manage scorpion sting emergencies and reduce complications. It supports investment in emergency care infrastructure, ensuring timely availability of life-saving therapies for high-risk and underserved regions. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, total healthcare expenditure saw a 5.6% increase in nominal terms in 2023, an increase of 0.9% growth compared to 2022. Therefore, the rising healthcare expenditure is driving the growth of the anascorp industry.

Key Players In The Global Anascorp Market

Major companies operating in the anascorp market are Instituto Bioclon S.A. de C.V.

What Defines the Anascorp Market?

The anascorp market consists of sales of products including Biosidus, ImmuVenom, Vins Bioproducts. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Anascorp Market Report 2026?

The anascorp market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the anascorp industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.